Andrew Hadd

Title: The Innovations of Andrew Hadd

Introduction

Andrew Hadd is a notable inventor based in Austin, TX, who has made significant contributions to the field of nucleic acid analysis. With a total of two patents to his name, his work focuses on advancing methods for detecting and analyzing genetic sequences. His innovative approaches have the potential to impact various areas of genetic research and diagnostics.

Latest Patents

Andrew Hadd's latest patents include "Methods for nucleic acid size detection of repeat sequences" and "mPCR methods for analyzing repeat sequences." The first patent discloses data processing and calculating annotation systems and devices for nucleic acid analysis. Specifically, it presents methods for sizing a repeat region of a nucleic acid sample using a ladder of amplification products. The second patent provides methods for determining the methylation status of GC-rich templates, utilizing GC reference standards to simultaneously characterize methylation status and CGG repeat length. These methods are particularly useful for detecting genotypes associated with GC-rich repeats, including Fragile X Syndrome.

Career Highlights

Andrew Hadd is currently employed at Asuragen, Inc., where he continues to develop innovative solutions in the field of genetic analysis. His work at Asuragen has allowed him to collaborate with other talented professionals in the industry, further enhancing the impact of his inventions.

Collaborations

Some of Andrew's notable coworkers include Gary J Latham and Liangjing Chen. Their collaborative efforts contribute to the advancement of research and development in nucleic acid analysis.

Conclusion

In summary, Andrew Hadd is a distinguished inventor whose work in nucleic acid analysis has led to significant advancements in the field. His patents reflect a commitment to innovation and a desire to improve genetic research methodologies.